1 June 2018

Three RIMLS researchers received each 800,000 euros to develop an innovative research project and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

Information about the RIMLS scientists and their research is given below.

How to read the genome

Simon van Heeringen (FNWI), theme Cancer development and immune defense.
A fertilized egg cell develops into a complete organism with many different cell types. How is this encoded in the genome? Biologists will compare the development of different animals. Using ‘big data’ they will train computer algorithms to understand cellular decisions. This knowledge will be essential for regenerative medicine.

Why do healthy people die of the flu?

Frank van de Veerdonk, theme Infectious diseases and global health
A pandemic is inevitable and will cost millions of lives including many healthy adults. Deadly complications of the flu are fungal infection or a life-threatening inflammatory response. This research will identify why these complications happen and can lead to treatment that can save lives during a severe flu season.

A microchip-based toolbox to treat osteoporosis

Alireza Dolatshahi-Pirouz, theme Reconstructive and regenerative medicine
Due to the aging population new innovations are needed for dealing with osteoporosis the most common disability among today’s elderly. Regenerative medicine can address this challenge through hydrogel- based stem cell therapies. The goal is to develop a toolbox for testing thousands of such therapies in a single experiment.
 

Related news items


Poster prize Lars Damen at 10th European Elastin Meeting

17 August 2018

At the 10th European Elastin Meeting, Lars Damen, theme Reconstructive and regenerative medicine, received the early-stage researcher award for his poster entitled “Development of tools to study the sulfation pattern of heparan sulfate involved in elastic fiber biology”.

read more

Merel Ritskes member of the 3RCC Scientific Advisory Board

8 August 2018

The 3RCC Scientific Advisory Board is responsible for providing scientific expertise to the 3RCC, evaluating grant applications and evaluating the progress and functioning of the center.

read more

WHO Toolkit Pregnant and breastfeeding women

8 August 2018

Stein Schalkwijk, Angela Colbers and David Burger (Pharmacy) developed the Toolkit in cooperation with Mark Mirochnick (Boston University) as a part of “Toolkit for research and development of paediatric antiretroviral drugs and formulations”.

read more

Natural Killer cell therapy Hematology teams up with MWH4impact

25 July 2018

The Departments of Laboratory Medicine and Hematology entered into a partnership with the Social impact foundation MWH4impact on Natural Killer cell therapy.

read more

Oscar Contreras Ortiz Award for Kirsten Kluivers

23 July 2018

Kirsten Kluivers, theme Reconstructive and regenerative medicine, and her team, received this grant for the publication entitled: “Risk factors for pelvic organ prolapse and its recurrence: a systematic review”.

read more

Prinses Beatrix Spierfonds grant for Rick Wansink and Frank Walboomers

23 July 2018

Rick Wansink, theme Nanomedicine, and Frank Walboomers, theme Reconstructive and regenerative medicine, have been awarded a 250.000 EUR grant of the Prinses Beatrix Spierfonds towards the study and elucidation of myotonic dystrophy, in a project entitled: Harmful RNA in myotonic dystrophy.

read more
  • Go to